Inicio > Cuidados Intensivos. Cuidados Críticos. > Nuevos senderos para el tratamiento de la neumonía asociada al ventilador > Página 5

Nuevos senderos para el tratamiento de la neumonía asociada al ventilador

30. Chastre J, Dugard J, Luyt CE. A pilot study of the humaneeredTM anti- PcrV monoclonal antibody, KB001, in mechanically-ventilated (MV) subjects colonized with Pseudomonas aeruginosa (Pa) [abstract]. Am J Respir Crit Care Med 2010; 181:A2274.

31. Meersseman W, Lagrou K, Spriet I. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35:1526–31.

32. Ricard JD, Roux D. Candida pneumonia in the ICU: myth or reality? Intensive Care Med 2009; 35:1500–2.

33. Azoulay E, Timsit JF, Tafflet M. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 2006; 129:110–7.

34. Roux D, Gaudry S, Dreyfuss D. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009; 37:1062–7.

35. Roux D, Khoy-Ear L, Gaudry S. Antifungal treatment prevents bacterial pneumonia during airway fungal colonization [abstract]. Am J Respir Crit Care Med 2010; 181:A3245.

36. Nseir S, Jozefowicz E, Cavestri B. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med 2007; 33:137–42.